vs
OUTFRONT Media Inc.（OUT）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
OUTFRONT Media Inc.的季度营收约是PHIBRO ANIMAL HEALTH CORP的1.4倍（$513.3M vs $373.9M），OUTFRONT Media Inc.净利率更高（18.9% vs 7.3%，领先11.5%），PHIBRO ANIMAL HEALTH CORP同比增速更快（20.9% vs 4.1%），OUTFRONT Media Inc.自由现金流更多（$93.3M vs $8.3M），过去两年PHIBRO ANIMAL HEALTH CORP的营收复合增速更高（19.2% vs 12.1%）
OUTFRONT Media Inc.是一家美国广告企业，业务覆盖美国本土，由首席执行官Nick Brien领导美洲区业务，核心经营广告牌及公共交通展示广告两大业务板块，是户外广告领域的重要参与者。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
OUT vs PAHC — 直观对比
营收规模更大
OUT
是对方的1.4倍
$373.9M
营收增速更快
PAHC
高出16.8%
4.1%
净利率更高
OUT
高出11.5%
7.3%
自由现金流更多
OUT
多$85.0M
$8.3M
两年增速更快
PAHC
近两年复合增速
12.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $513.3M | $373.9M |
| 净利润 | $96.8M | $27.5M |
| 毛利率 | — | 35.5% |
| 营业利润率 | 26.0% | 13.5% |
| 净利率 | 18.9% | 7.3% |
| 营收同比 | 4.1% | 20.9% |
| 净利润同比 | 30.8% | 762.1% |
| 每股收益（稀释后） | $0.57 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUTPAHC
| Q4 25 | $513.3M | $373.9M | ||
| Q3 25 | $467.5M | $363.9M | ||
| Q2 25 | $460.2M | $378.7M | ||
| Q1 25 | $390.7M | $347.8M | ||
| Q4 24 | $493.2M | $309.3M | ||
| Q3 24 | $451.9M | $260.4M | ||
| Q2 24 | $477.3M | $273.2M | ||
| Q1 24 | $408.5M | $263.2M |
净利润OUTPAHC
| Q4 25 | $96.8M | $27.5M | ||
| Q3 25 | $51.3M | $26.5M | ||
| Q2 25 | $19.5M | $17.2M | ||
| Q1 25 | $-20.6M | $20.9M | ||
| Q4 24 | $74.0M | $3.2M | ||
| Q3 24 | $34.6M | $7.0M | ||
| Q2 24 | $176.8M | $752.0K | ||
| Q1 24 | $-27.2M | $8.4M |
毛利率OUTPAHC
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 29.0% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.2% |
营业利润率OUTPAHC
| Q4 25 | 26.0% | 13.5% | ||
| Q3 25 | 19.2% | 14.1% | ||
| Q2 25 | 12.2% | 8.9% | ||
| Q1 25 | 3.6% | 9.6% | ||
| Q4 24 | 22.5% | 8.3% | ||
| Q3 24 | 15.8% | 6.8% | ||
| Q2 24 | 48.0% | 6.7% | ||
| Q1 24 | 3.4% | 7.6% |
净利率OUTPAHC
| Q4 25 | 18.9% | 7.3% | ||
| Q3 25 | 11.0% | 7.3% | ||
| Q2 25 | 4.2% | 4.5% | ||
| Q1 25 | -5.3% | 6.0% | ||
| Q4 24 | 15.0% | 1.0% | ||
| Q3 24 | 7.7% | 2.7% | ||
| Q2 24 | 37.0% | 0.3% | ||
| Q1 24 | -6.7% | 3.2% |
每股收益（稀释后）OUTPAHC
| Q4 25 | $0.57 | $0.67 | ||
| Q3 25 | $0.29 | $0.65 | ||
| Q2 25 | $0.10 | $0.43 | ||
| Q1 25 | $-0.14 | $0.51 | ||
| Q4 24 | $0.49 | $0.08 | ||
| Q3 24 | $0.19 | $0.17 | ||
| Q2 24 | $1.01 | $0.02 | ||
| Q1 24 | $-0.18 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $99.9M | $74.5M |
| 总债务越低越好 | — | $624.2M |
| 股东权益账面价值 | $710.4M | $332.4M |
| 总资产 | $5.3B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 1.88× |
8季度趋势，按日历期对齐
现金及短期投资OUTPAHC
| Q4 25 | $99.9M | $74.5M | ||
| Q3 25 | $63.0M | $85.3M | ||
| Q2 25 | $28.5M | $77.0M | ||
| Q1 25 | $30.5M | $70.4M | ||
| Q4 24 | $46.9M | $67.1M | ||
| Q3 24 | $28.0M | $89.8M | ||
| Q2 24 | $49.6M | $114.6M | ||
| Q1 24 | $42.4M | $98.7M |
总债务OUTPAHC
| Q4 25 | — | $624.2M | ||
| Q3 25 | — | $628.0M | ||
| Q2 25 | — | $631.7M | ||
| Q1 25 | — | $635.4M | ||
| Q4 24 | — | $639.1M | ||
| Q3 24 | — | $295.2M | ||
| Q2 24 | — | $312.1M | ||
| Q1 24 | — | — |
股东权益OUTPAHC
| Q4 25 | $710.4M | $332.4M | ||
| Q3 25 | $542.6M | $311.7M | ||
| Q2 25 | $539.1M | $285.7M | ||
| Q1 25 | $566.9M | $266.0M | ||
| Q4 24 | $649.0M | $246.8M | ||
| Q3 24 | $618.2M | $258.5M | ||
| Q2 24 | $664.9M | $256.6M | ||
| Q1 24 | $524.2M | $270.1M |
总资产OUTPAHC
| Q4 25 | $5.3B | $1.4B | ||
| Q3 25 | $5.2B | $1.4B | ||
| Q2 25 | $5.1B | $1.4B | ||
| Q1 25 | $5.1B | $1.3B | ||
| Q4 24 | $5.2B | $1.3B | ||
| Q3 24 | $5.2B | $966.3M | ||
| Q2 24 | $5.3B | $982.2M | ||
| Q1 24 | $5.5B | $979.0M |
负债/权益比OUTPAHC
| Q4 25 | — | 1.88× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 2.59× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $118.1M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | $93.3M | $8.3M |
| 自由现金流率自由现金流/营收 | 18.2% | 2.2% |
| 资本支出强度资本支出/营收 | 4.8% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.22× | 0.70× |
| 过去12个月自由现金流最近4个季度 | $218.8M | $47.3M |
8季度趋势，按日历期对齐
经营现金流OUTPAHC
| Q4 25 | $118.1M | $19.4M | ||
| Q3 25 | $88.8M | $9.3M | ||
| Q2 25 | $67.1M | $21.3M | ||
| Q1 25 | $33.6M | $43.2M | ||
| Q4 24 | $124.5M | $3.1M | ||
| Q3 24 | $73.1M | $12.6M | ||
| Q2 24 | $71.0M | $28.4M | ||
| Q1 24 | $30.6M | $11.4M |
自由现金流OUTPAHC
| Q4 25 | $93.3M | $8.3M | ||
| Q3 25 | $67.7M | $-4.5M | ||
| Q2 25 | $41.4M | $8.1M | ||
| Q1 25 | $16.4M | $35.4M | ||
| Q4 24 | $106.3M | $-4.7M | ||
| Q3 24 | $55.5M | $3.0M | ||
| Q2 24 | $47.1M | $15.4M | ||
| Q1 24 | $12.2M | $1.7M |
自由现金流率OUTPAHC
| Q4 25 | 18.2% | 2.2% | ||
| Q3 25 | 14.5% | -1.2% | ||
| Q2 25 | 9.0% | 2.1% | ||
| Q1 25 | 4.2% | 10.2% | ||
| Q4 24 | 21.6% | -1.5% | ||
| Q3 24 | 12.3% | 1.2% | ||
| Q2 24 | 9.9% | 5.6% | ||
| Q1 24 | 3.0% | 0.6% |
资本支出强度OUTPAHC
| Q4 25 | 4.8% | 3.0% | ||
| Q3 25 | 4.5% | 3.8% | ||
| Q2 25 | 5.6% | 3.5% | ||
| Q1 25 | 4.4% | 2.2% | ||
| Q4 24 | 3.7% | 2.5% | ||
| Q3 24 | 3.9% | 3.7% | ||
| Q2 24 | 5.0% | 4.8% | ||
| Q1 24 | 4.5% | 3.7% |
现金转化率OUTPAHC
| Q4 25 | 1.22× | 0.70× | ||
| Q3 25 | 1.73× | 0.35× | ||
| Q2 25 | 3.44× | 1.24× | ||
| Q1 25 | — | 2.07× | ||
| Q4 24 | 1.68× | 0.97× | ||
| Q3 24 | 2.11× | 1.81× | ||
| Q2 24 | 0.40× | 37.80× | ||
| Q1 24 | — | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OUT
| Static Displays | $236.3M | 46% |
| Other | $134.8M | 26% |
| Digital Displays | $125.3M | 24% |
| Other Revenues | $1.9M | 0% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
